flunixin meglumine (Banamine)

Subscribe to Selected New Research on flunixin meglumine

95 relevant articles (11 outcomes, 13 trials/studies) found for this Bio-Agent

Description: structure

Also Known As:

Banamine; Sch 14714 meglumine; finadyne; 2-((2-methyl-3-(trifluoromethyl)- phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Pyridines: 26

Nicotinic Acids: 11

Clonixin: 5

flunixin meglumine: 95

Heterocyclic Acids

Nicotinic Acids: 11

Clonixin: 5

flunixin meglumine: 95

Experts

1.	Fthenakis, G C: 2 articles (10/2004 - 12/2000)
2.	Elmas, M: 1 article (09/2007)
3.	Altunok, V: 1 article (09/2007)
4.	Uney, K: 1 article (09/2007)
5.	Yazar, E: 1 article (09/2007)
6.	Er, A: 1 article (09/2007)
7.	MacAllister, Charles G: 1 article (02/2005)
8.	Payton, Mark E: 1 article (02/2005)
9.	Clarke, Cyril R: 1 article (02/2005)
10.	Erkert, Ronald S: 1 article (02/2005)

Related Diseases

1.	Pain (Aches) 06/01/2008 - "Behavioural pain scores did not increase significantly after surgery in horses treated with flunixin meglumine" 01/01/1996 - "One goat in the saline group required two intravenous injections of flunixin meglumine for pain." 01/01/1990 - "In the "heating element" model, a 1.1 mg/kg i.v. dose of flunixin meglumine failed to inhibit the peripheral pain, while it could be shown that a 0.7 mg/kg i.v. dose of carprofen inhibited the peripheral perception of pain in horses for approximately 24 hours after the drug injection" 03/01/1997 - "Thus, a dose-response plateau for eltenac was reached at 0.5 mg/kg. Comparison with flunixin meglumine at a dosage of 1.1 mg/kg did not indicate significant differences between the 2 treatment groups at the pivotal time of 96 hours for carpal circumference, carpal flexion angle, stride length, carpal hyperthermia, and signs of carpal pain" 06/15/2008 - "Objective-To compare efficacy of flunixin meglumine versus carprofen in controlling pain under field conditions following castration by use of an external clamping technique in calves that received epidural anesthesia" Order ALL the reference details at left...
2.	Body Weight (Weight, Body) 08/01/2007 - "The objective of this field trial was to evaluate effects of a single administration of 2.2 mg/kg of body weight (BW) of flunixin meglumine (FM) in addition to a systemic antibiotic treatment in cows with acute puerperal metritis (APM)" 01/04/1986 - "In a double blind trial the calves were injected intravenously with either flunixin meglumine (2 mg/kg body weight) or with a placebo" 01/01/2008 - "The pharmacokinetics of flunixin meglumine was determined after its multiple (altogether 4 doses at 24-hours intervals) intravenous administration at a dose of 2.2 mg/kg body weight in six mature clinically healthy heifers" 04/15/2000 - "In the second estrus, six sows were given intravenous injections of flunixin meglumine (2.2 mg/kg body weight) every sixth hour from 4 to 8 h after time of ovulation until about 48 h after ovulation, at which time the sows were slaughtered" 11/01/1999 - "PROCEDURE: Blood samples were collected at time zero (before) and 5, 10, 15, 30, and 45 minutes, and at 1, 1.25, 1.5, 1.75, 2, 2.5, 2.75, 3, 3.5, 4, 4.5, 5, 5.5, 6, and 8 hours after i.v. administration of a bolus of flunixin meglumine (1.1 mg/kg of body weight)" Order ALL the reference details at left...
3.	Shock 09/01/1997 - "The application of the prostanoid synthesis inhibitor flunixin meglumine can be judged as being effective in limiting shock progress in the peri-operative setting given reliable diagnosis." 07/01/1985 - "A study was conducted to determine whether body fluids undergo a net shift from one compartment to another during endotoxin-induced shock in the pony, and whether flunixin meglumine alters these endotoxin-induced changes in the volumes of body fluid compartments" 09/01/1981 - "Three groups of 5 ponies each were used: controls--group 1; given endotoxin but not treated--group 2; and given endotoxin and treated with flunixin meglumine--group 3. Shock was induced in anesthetized ponies with IV injection of Escherichia coli endotoxin" 06/01/1982 - "This study had 2 objectives: (i) to correlate plasma thromboxane and prostaglandin I2 (epoprostenol) concentrations with hemodynamic changes occurring in equine endotoxin shock, and (ii) to determine the effects of flunixin meglumine on plasma concentrations of these prostaglandins relative to hemodynamic changes" 01/01/1985 - "To evaluate the effect of certain drugs on hematologic changes, blood chemical values, and survival in endotoxin shock, anesthetized ponies were given (IV) endotoxin (Escherichia coli O55:B5) and then treated as follows: Group A ponies--given a saline infusion at 5 minutes and at 3 hours after they were given endotoxin; group B ponies--given flunixin meglumine at 5 minutes and at 3, 6, 9, and 24 hours after they were given endotoxin; group C ponies--treated with dexamethasone; and group D ponies--treated with prednisolone at 5 minutes and at 3, 9, and 24 hours after they were given endotoxin" Order ALL the reference details at left...
4.	Endotoxemia 07/01/1987 - "Seemingly, flunixin meglumine helped to maintain acceptable cardiovascular function and tissue perfusion during endotoxemia" 09/01/2007 - "As result, flunixin meglumine showed depressor effect on cytokine levels in endotoxemia and the effect may be a reason for the first chosen member of nonsteroid anti-inflammatory drug in endotoxemia." 09/01/2007 - "Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice." 01/01/1997 - "Treatments used to attempt to prevent development of endotoxemia or to treat horses with endotoxemia included i.v. fluids and administration of broad-spectrum antimicrobials and flunixin meglumine." 07/01/1988 - "Effects of flunixin meglumine in dogs following experimentally induced endotoxemia." Order ALL the reference details at left...
5.	Heat Stress Disorders (Heat Stress) 06/01/1982 - "All levels of Banamine appeared to give some measure of protection against heat stress in male broilers as evidenced by higher survival rates and longer survival times." 06/01/1982 - "Two trials were conducted using broiler chickens to test the efficacy of pretreatment with Banamine, an inhibitor of prostaglandin synthesis, on various heat stress indices" Order ALL the reference details at left...

Related Drugs and Biologics

1.	carprofen
2.	meloxicam (Mobic)
3.	Ranitidine (Zantac)
4.	Sodium Chloride (Saline Solution)
5.	eltenac
6.	bismuth subsalicylate (Pepto-bismol)
7.	Epoprostenol (Prostacyclin)
8.	Dinoprost
9.	Oxytetracycline (Terramycin)
10.	Interleukin-1beta (Interleukin 1 beta)

Related Therapies and Procedures

1.	Castration
2.	Epidural Anesthesia
3.	Fluid Therapy (Oral Rehydration Therapy)
4.	Euthanasia (Mercy Killing)
5.	Analgesia

Best Treatments:
Research Summary Report
on Pain

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 8434 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>